Apoptosis of granulosa cells and female infertility in achondroplastic mice expressing mutant fibroblast growth factor receptor 3G374R

Molecular Endocrinology

Volumn 15, Issue 9, 2001, Pages 1610-1623

  Amsterdam, A ^a   Kannan, K ^a   Givol, D ^a   Yoshida, Y ^a   Tajima, K ^a   Dantes, A ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 3; MUTANT PROTEIN;

ACHONDROPLASIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL AGING; CELL GROWTH; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; GRANULOSA CELL; HISTOPATHOLOGY; HORMONE DETERMINATION; MORPHOMETRICS; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0034831134     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.15.9.0700     Document Type: Article

References (56)

1. Fibroblast growth factors and their receptors
2. Fibroblast growth factors as multi-functional signaling factors
3. FGFs, heparan sulfate and FGFRS: Complex interactions essential for development
4. Structural basis for FGF receptor dimerization and activation
5. The FGF family of growth factors and oncogenes
6. Fibroblast growth factor receptors (FGFRs) and their roles in limb development
7. FGF signaling in skeletal development
8. Effect of fibroblast and epidermal growth factors on ovarian cell proliferation in vitro. I. Characterization of the response of granulosa cells for FGF and EGF
9. Effect of fibroblast and epidermal growth factors on ovarian cell proliferation in vitro. II. Proliferative reponse of luteal cells to FGF but not EGF
10. Fibroblast and epidermal growth factors are mitogenic agents for cultured granulosa cells of rodent, porcine and human origin
11. Growth factors modulate gonadotropin receptor induction in granulosa cell cultures
12. Fibroblast growth factor as an intraovarian hormone: Differential regulation of steroidogenesis by an angiogenic factor
13. Basic fibroblast growth factor as a regulator of ovarian granulosa cell differentiation: A novel non-mitogenic role
14. Regulation of luteinizing hormone receptor messenger ribonucleic acid levels by gonadotropins, growth factors, and gonadotropin-releasing hormone in cultured rat granulosa cells
15. cAMP-mediated signals as determinants for apoptosis in primary granulosa cells
16. Differential effect of components of the extracellular matrix on differentiation and apoptosis
17. Basic fibroblast growth factor induction of granulosa cell tissue-type plasminogen activator expression and oocyte maturation: Potential role as a paracrine ovarian hormone
18. Local nonsteroidal regulators of ovarian function
19. FGF receptor mutations: Dimerization syndromes, cell growth suppression, and animal models
20. Fibroblast-growth-factor receptor mutations in human skeletal disorders
21. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: The achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans
22. FGFR activation in skeletal disorders: Too much of a good thing
23. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia
24. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
25. A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3
26. Cross-talk between adenylate cyclase activation and tyrosine phosphorylation leads to modulation of the actin cytoskeleton and to acute progesterone secretion in ovarian granulosa cells
27. Developmental expression and regulation of the gap junction protein and transcript in rat ovaries
28. Coincident expression of phosphotyrosine FGFR-1 during ovarian follicular development and differentiation
29. Fibroblast growth factor receptor (FGFR)-4, but not FGFR-3 is expressed in the pregnant ovary
30. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway
31. Activation of Stat1 by mutant fibroblast growth factor receptor in thanatophoric dysplasia type II dwarfism
32. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and INK4 cell cycle inhibitors
33. Fibroblast growth factor receptor 3 is a negative regulator of bone growth
34. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3
35. Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3
36. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts
37. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia
38. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism
39. A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos
40. Endocrine defects in mice carrying a null mutation for the progesterone receptor gene
41. Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland
42. Neuroendocrine regulation of GnRH release in induced ovulators
43. Reproductive biology of PMSG-primed immature female rats
44. Coordinated regulation of morphological biochemical differentiation in a steroidogenic cell: The granulosa cell model
45. Crosstalk among multiple signaling pathways controlling ovarian cell death
46. Modulation of Mdm2 expression and p53 induced apoptosis in immortalized human ovarian granulosa cells
47. Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes
48. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
49. Induction of Ad4BP/SF-1, steroidogenic acute regulatory protein, and cytochrome p450scc enzyme system expression in newly established human granulosa cell lines
50. Preparation of antigenic steroid-protein conjugates
51. Establishment of steroidogenic granulosa cell lines expressing follicle stimulating hormone receptors
52. Introduction of a gonadotropin receptor expression plasmid into immortalized granulosa cells leads to reconstitution of hormone-dependent steroidogenesis
53. Establishment of an in vitro bioassay and radio receptor assay for LH/CG in human sera using immortalized granulosa cells transfected with LH/CG receptor
54. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
55. The proteasome is involved in the first metaphase-to-anaphase transition of meiosis in rat ooctyes
56. 365→Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia